← All trials
NCT04616781
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2020
- Primary completion
- Jan 31, 2024
- Completion date
- Sep 30, 2024
- First posted
- Nov 5, 2020
- Last posted
- Nov 5, 2020
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PennsylvaniaLead sponsor
- University of PennsylvaniaOverall official - principal investigator
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.